StockData

Intellicheck vs Intellinetics

IDN and INLX side by side, both in computer programming, data processing, and other computer related services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How IDN and INLX compare

Intellicheck is the larger company, worth 2.0 times as much as Intellinetics ($33.7M against $17.1M).

Intellicheck grew revenue faster over the last twelve months (16.7% versus −5.5% for Intellinetics).

Intellicheck keeps more of each dollar of sales as profit, with a net margin of 13.0% compared with −17.6% at Intellinetics.

Intellicheck scores higher on the StockData Score (16 against 8 for Intellinetics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricIDNINLX
Size and price
Market cap$33.7M$17.1M
Share price$1.67$3.80
Change, 1 year−73.1%−57.6%
Change, 5 years−66.8%−52.8%
Beta (5Y)1.840.09
Employees38147
StockData Score
Total score16 (better)8
Valuation score4 (better)3
Growth score3 (better)1
Performance score4 (better)0
Health score5 (better)4
Dividend score00
Valuation
P/E11.9×–
P/S1.4×1.1× (better)
P/B1.5× (better)1.7×
EV/EBITDA6.1×–
P/FCF12.0× (better)36.5×
FCF yield8.3% (better)2.7%
Fair value$3.76$6.21
Margin of safety55.7% (better)38.8%
Growth
Revenue growth (TTM)16.7% (better)−5.5%
Revenue growth, 5Y average16.1% (better)15.0%
Profitability
Gross margin91.1% (better)65.2%
Operating margin11.8% (better)−17.7%
Net margin13.0% (better)−17.6%
FCF margin11.7% (better)2.9%
Return on equity15.5% (better)−26.6%
Return on invested capital27.8% (better)−25.8%
Financial health
Debt / equity0.000.00
Current ratio4.98 (better)0.75
Altman Z-score1.24 (better)−0.22
Piotroski F-score7 (better)5
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions52.3%10.5%
Held by insiders5.2%57.5%
Insider net buying, 12 months−$344K−$14.1K (better)
Short interest, % of float5.6%0.19%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.